Endocrinology

Targeting the Incretin Pathways in Type 2 Diabetes

05/28/2015

Ralph A. DeFronzo, MD, discusses the utilization of glucagon-like peptide-1 (GLP-1) agonists and incorporating evidence-based guidelines into practice when considering the use of incretin-based therapies for type 2 diabetes.

For mFor more videos, visit our partners at The Doctor's Channel.

Related Content

Gastroenterology
Gastroenterology
Dermatologic Challenges in the Management of Inflammatory Bowel Disease
07/31/2018
07/31/2018
Gastroenterology
video
Gastroenterology
What New and Future Endoscopic Advances Will Help Us to Better Diagnose and Manage IBD Patients?
08/08/2018
08/08/2018
Gastrointestinal Disorders
Sara Horst
Gastrointestinal Disorders
Sara Horst, MD, MPH, on Managing Opportunistic Infections in IBD
07/03/2019
In this video, Sara Horst, MD, MPH, from Vanderbilt University Medical Center, discusses how she manages opportunistic infections among patients with IBD.
07/03/2019
Nutrition
Leah Sarris, Timothy S. Harlan, and Edward Shahady
Nutrition
CRS 2014: Translating the Research on Mediterranean Diet for Your Patient's Kitchen
10/10/2014
2014 Summit Faculty Leah Sarris, BS, and Co-Chairs Timothy S. Harlan, MD, and Edward Shahady MD, FAAFP, ABCL, discuss the live cooking demonstration presented at the Summit in collaboration with the...
10/10/2014
Cardiometabolic Risk
Cardiometabolic Risk
James Matera, MD, on Managing Hyperkalemia With Novel Potassium Binders to Achieve Optimal Outcomes
11/18/2019
James Matera, MD, talks about the association between cardiometabolic diseases and hyperkalemia, the benefits and risks of various treatment approaches for chronic hyperkalemia, and more.
11/18/2019